EPISODE · Jul 12, 2025 · 10 MIN
Stage 1 and 2 NSCLC Lung Cancer: Early Detection, Treatment Options & Recovery Insights
In this episode, we explore everything you need to know about Stage 1 and 2 NSCLC lung cancer—the most common type of lung cancer—focusing on early detection, treatment approaches, and what patients can expect during recovery.You’ll learn:The key differences between Stage 1 and Stage 2 NSCLC lung cancerWhy early-stage diagnosis dramatically improves treatment outcomesSurgical options including lobectomy and VATS for early-stage tumorsHow radiation and chemotherapy support treatment plansThe importance of identifying your NSCLC subtype for targeted therapyWhat ongoing surveillance and follow-up care look like after treatmentCommon patient questions answered, including curability of Stage 2 NSCLCWhether you or a loved one has been diagnosed or you're simply seeking to understand early-stage lung cancer, this episode offers clear guidance and hopeful insights.Blog Link: Lung Cancer Treatment in MalaysiaSend us Fan MailThank you for listening to The Onco Life Podcast, your trusted source for expert cancer information and patient-centered education.Author: Dr. CHRISTINA NG VAN TZE📍 Visit us at oncolifecentre.com 📞 Call: +603-2242-2620 📧 Book a consultation or ask a question — we're here to support your journey.
What this episode covers
In this episode, we explore everything you need to know about Stage 1 and 2 NSCLC lung cancer—the most common type of lung cancer—focusing on early detection, treatment approaches, and what patients can expect during recovery. You’ll learn: The key differences between Stage 1 and Stage 2 NSCLC lung cancerWhy early-stage diagnosis dramatically improves treatment outcomesSurgical options including lobectomy and VATS for early-stage tumorsHow radiation and chemotherapy support treatment plansThe...
NOW PLAYING
Stage 1 and 2 NSCLC Lung Cancer: Early Detection, Treatment Options & Recovery Insights
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m